Investment Analysts’ price target changes for Tuesday, October 22nd:
AIM ImmunoTech (NYSE:AIM) had its price target reduced by Maxim Group from $2.00 to $1.00. They currently have a buy rating on the stock.
AppLovin (NASDAQ:APP) had its target price boosted by Citigroup Inc. from $155.00 to $185.00. The firm currently has a buy rating on the stock.
Brookfield Renewable Partners (NYSE:BEP) (TSE:BEP) had its target price raised by CIBC from $33.00 to $34.00. CIBC currently has an outperformer rating on the stock.
Clearway Energy (NYSE:CWEN) had its target price increased by CIBC from $33.00 to $34.00. They currently have an outperformer rating on the stock.
Editas Medicine (NASDAQ:EDIT) had its price target trimmed by Chardan Capital from $20.00 to $12.00. They currently have a buy rating on the stock.
Fiserv (NYSE:FI) had its price target raised by Jefferies Financial Group Inc. from $195.00 to $200.00. The firm currently has a hold rating on the stock.
Genuine Parts (NYSE:GPC) had its target price reduced by JPMorgan Chase & Co. from $162.00 to $135.00. The firm currently has an overweight rating on the stock.
IAMGOLD (NYSE:IAG) (TSE:IMG) had its price target boosted by CIBC from $5.40 to $6.40. They currently have a neutral rating on the stock.
NextEra Energy Partners (NYSE:NEP) had its price target trimmed by CIBC from $34.00 to $32.00. The firm currently has a neutral rating on the stock.
Norfolk Southern (NYSE:NSC) had its price target raised by Citigroup Inc. from $294.00 to $302.00. They currently have a buy rating on the stock.
Regeneron Pharmaceuticals (NASDAQ:REGN) had its price target cut by Wells Fargo & Company from $1,200.00 to $1,050.00. Wells Fargo & Company currently has an overweight rating on the stock.
Viking (NYSE:VIK) had its target price increased by Barclays PLC from $39.00 to $43.00. The firm currently has an overweight rating on the stock.
Western Alliance Bancorporation (NYSE:WAL) had its price target trimmed by Barclays PLC from $110.00 to $105.00. Barclays PLC currently has an overweight rating on the stock.
Williams Companies (NYSE:WMB) had its price target boosted by CIBC from $45.00 to $54.00. CIBC currently has a neutral rating on the stock.
Zions Bancorporation, National Association (NASDAQ:ZION) had its target price increased by Barclays PLC from $47.00 to $52.00. Barclays PLC currently has an underweight rating on the stock.
Receive News & Ratings for AIM ImmunoTech Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AIM ImmunoTech Inc and related companies with MarketBeat.com's FREE daily email newsletter.